Warnex has announced that it has become the exclusive Canadian distributor of molecular diagnostic tests for Gendia, an international network offering more than 2,000 different genetic tests.
'Warnex will assist healthcare professionals in detecting rare genetic disorders by offering tests that are not readily available in Canada,' said Mark Busgang, president and chief executive of Warnex.
'By collaborating with this network, we are making these uncommon tests more affordable while providing faster results.' Gendia's mission is to improve the accessibility, cost-effectiveness and quality of genetic diagnostics on a global scale.
Since most laboratories offer a limited number of molecular tests, the majority of genetic disorders cannot be diagnosed locally or even nationally.
This network provides the opportunity to access specific tests worldwide.
